Medomics Seeks to Raise up to $4M for Sequencing-Based Mitochondrial Disease Dx

The company expects to receive a $1 million investment from an undisclosed corporate co-investor if it can raise $2 million to $3 million in add-on funding.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.